参考文献/References:
[1] 朱秀梅,黄亚川,范荣辉.氟尿嘧啶配伍曲安奈德治疗瘢痕疙瘩46例[J].陕西医学杂志,2016,45(9):1241-1242.
[2] 崔 晶,金哲虎,金 珊,等.多配体蛋白聚糖-1对瘢痕疙瘩成纤维细胞增殖及迁移的影响[J].中国皮肤性病学杂志,2020,34(6):617-621.
[3] Ogawa R,Dohi T,Tosa M,et al.The latest strategy for keloid and hypertrophic scar prevention and treatment:The Nippon Medical School(NMS)protocol[J].J Nippon Med Sch,2021,88(1):2-9.
[4] 张慧娟,王 强,姚 放.异甘草素对瘢痕疙瘩成纤维细胞胶原合成的影响及机制[J].实用皮肤病学杂志,2021,14(5):261-265.
[5] 岳宗进,刘汝银,于 露,等.补骨脂素调控SKP2/PTHrP/SIRT1轴缓解炎症环境下髓核细胞退变的作用[J].解放军医学杂志,2021,46(7):657-665.
[6] 杨 洛,唐凤娟,张 祥,等.松果菊苷通过调控SIRT1/PGC-1α信号通路改善肥胖糖尿病小鼠肝损伤[J].医学研究杂志,2020,49(3):85-89,60.
[7] Liu T,Ma X,Ouyang T,et al.Efficacy of 5-aminolevulinic acid-based photodynamic therapy against keloid compromised by downregulation of SIRT1-SIRT3-SOD2-mROS dependent autophagy pathway [J].Redox Biol,2019,20:195-203.
[8] Bai XZ,Liu JQ,Yang LL,et al.Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars[J].Br J Pharmacol,2016,173(10):1589-1601.
[9] 戴晓刚,李小莹,余厚友.自体脂肪移植联合脉冲染料激光治疗烧伤后增生性瘢痕效果及对患者瘢痕血流灌注的影响[J].陕西医学杂志,2021,50(11):1404-1407.
[10] 吕开阳,夏照帆.中日两国瘢痕及瘢痕疙瘩的诊治异同与思考[J].中华烧伤杂志,2021,37(4):306-311.
[11] Zhang Y,Anoopkumar-Dukie S,Arora D,et al.Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases[J].Eur J Pharmacol,2020,867:172847.
[12] 曹 佳,杨华英,何 艺,等.姜黄素通过激活SIRT1调节脓毒症小鼠模型的认知功能障碍研究[J].陕西中医,2020,41(3):301-307.
[13] Palmieri B,Vadalà M,Laurino C.Nutrition in wound healing:Investigation of the molecular mechanisms,a narrative review[J].J Wound Care,2019,28(10):683-693.
[14] Rodrigues M,Kosaric N,Bonham CA,et al.Wound healing:A cellular perspective[J].Physiol Rev,2019,99(1):665-706.
[15] Li K,Zhai M,Jiang L,et al.Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway[J].Oxid Med Cell Longev,2019,2019:6746907.
[16] Song L,Chen TY,Zhao XJ,et al.Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling[J].Br J Pharmacol,2019,176(11):1619-1634.
[17] Chen L,Wang Y,Li S,et al.Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway[J].Theranostics,2020,10(20):9425-9442.
[18] Jiang L,Deng Y,Li W,et al.Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress[J].Mol Med Rep,2020,22(6):4783-4791.
[19] 李仕一,杨锦秀,陈敏亮.氧化应激与病理性瘢痕研究进展[J].中华医学美学美容杂志,2020,26(5):454-456.
[20] Singh V,Ubaid S.Role of silent information regulator 1(SIRT1)in regulating oxidative stress and inflammation[J].Inflammation,2021,44(5):2142.